Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adverse Events
9%
ANCA-associated
100%
Antineutrophil
9%
Autoantibodies
9%
Cytokine Levels
18%
Disease Outcome
9%
Disease Stage
9%
ELISA Kit
9%
Glomerulonephritis
9%
Immunoglobulin M
9%
In-house ELISA
9%
Inflammatory Disorders
9%
Interleukin-8
36%
Monocyte Chemoattractant protein-1 (MCP-1)
100%
Poor Prognosis
18%
Relapse Pattern
18%
Relapsing-remitting
9%
Renal Inflammation
9%
Stable Phase
18%
Statistical Significance
9%
Urinary Cytokines
9%
Urinary Levels
9%
Immunology and Microbiology
Autoantibodies
20%
Glomerulonephritis
20%
Inflammatory Disorder
20%
Interleukin 6
20%
Interleukin 8
20%
Monocyte Chemotactic Protein 1
100%
Nephritis
20%
Urine Level
20%
Vasculitis
100%
Neuroscience
Autoantibodies
20%
Immunoglobulin M
100%
Interleukin 6
20%
Interleukin 8
20%
Monocyte Chemotactic Protein 1
100%
Medicine and Dentistry
Adverse Event
20%
Autoantibodies
20%
Glomerulonephritis
20%
Inflammatory Disorder
20%
Interleukin 6
20%
Interleukin 8
20%
Monocyte Chemotactic Protein 1
100%
Nephritic Syndrome
20%
Pharmacology, Toxicology and Pharmaceutical Science
Autoantibodies
20%
Enzyme-Linked Immunosorbent Assay
40%
Glomerulonephritis
20%
Interleukin 8
20%
Monocyte Chemotactic Protein 1
100%
Nephritis
20%